| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/15/1997 | EP0753577A1 Cell-surface polypeptide gene |
| 01/15/1997 | EP0753528A1 Prostaglandin i 2? receptor |
| 01/15/1997 | EP0753527A1 Prostaglandin e receptor |
| 01/15/1997 | EP0753526A1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient |
| 01/15/1997 | EP0753310A1 Legionellosis vaccines and methods for their production |
| 01/15/1997 | EP0753309A2 Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases |
| 01/15/1997 | EP0753308A2 Use of lactoferrin for therapy of acute or recurrent infectious diseases by streptococcus pyogenes or other intracellular gram positive pathogen bacteria |
| 01/15/1997 | EP0753307A2 Human growth hormone agent for adults |
| 01/15/1997 | EP0753304A1 Thrombolytic enzyme and method of obtaining same |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0753069A1 Gene delivery fusion proteins |
| 01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
| 01/15/1997 | EP0753066A1 Recombinant bcg vaccines |
| 01/15/1997 | EP0753065A1 Antibodies against e-selectin |
| 01/15/1997 | EP0753063A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting |
| 01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 01/15/1997 | EP0753060A1 Conserved t-cell receptor sequences |
| 01/15/1997 | EP0753055A1 Enzymatic antimicrobial compositions |
| 01/15/1997 | EP0753015A1 Monoclonal antibodies recognizing tie-receptor and their use |
| 01/15/1997 | EP0753014A1 IgM-SPECIFIC RECOMBINANT RHEUMATOID ARTHRITIS ANTIGEN |
| 01/15/1997 | EP0753013A1 Neurotrophin-6: a new member of the neurotrophin family |
| 01/15/1997 | EP0753012A1 A new 78 residue polypeptide (nk-lysine) and its use |
| 01/15/1997 | EP0753010A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 01/15/1997 | EP0753007A1 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0753005A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0753003A1 Aziridine derivatives, their production and use |
| 01/15/1997 | EP0752987A1 Pyrimidinyl derivatives as interleukin inhibitors |
| 01/15/1997 | EP0752884A1 Method of treating auto-immune diseases using type one interferons |
| 01/15/1997 | EP0752883A1 Use of mcp-1 for inducing ripening of the cervix |
| 01/15/1997 | EP0752882A1 Treatment for juvenile diabetes |
| 01/15/1997 | EP0752881A1 A novel brain endothelial cell protein and methods for its use |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
| 01/15/1997 | EP0752878A1 Products comprising substrates capable of enzymatic cross-linking |
| 01/15/1997 | EP0752877A1 Stabilized composition for oral administration of peptides |
| 01/15/1997 | EP0752876A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 01/15/1997 | EP0752875A1 Glioblastoma-derived angiogenesis inhibiting factor |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752873A1 Labelled peptide compounds |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752868A1 Improved methods for transplantation using modified cells and t cell inhibitory agents |
| 01/15/1997 | EP0752867A1 Selective cell proliferation |
| 01/15/1997 | EP0752866A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 01/15/1997 | EP0752863A1 Use of biopolymers for digestive tract injuries treatment |
| 01/15/1997 | EP0752858A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction |
| 01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0671938A4 Novel biologically active peptides and uses therefor. |
| 01/15/1997 | EP0642332B1 Ophthalmic compositions containing a cyclosporin |
| 01/15/1997 | EP0514451B1 Dietary supplements comprising vitamins and minerals |
| 01/15/1997 | EP0440742B1 Liposome immunoadjuvants containing il-2 |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140455A Diastereomeric pure trifluoromethyl ketone peptide derivs. as inhibitors of human leukocyte elastase |
| 01/15/1997 | CN1140454A Novel mercaptoacetylamido-1,3,4,5-tetrahydro-benzo|c¨ azepin-3-one disulfide derivs. useful as inhibitors of enkephalinase and ACE |
| 01/15/1997 | CN1140414A Use of anti-TNF antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels |
| 01/15/1997 | CN1140413A Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 01/15/1997 | CN1140089A Oral liquid of collagen protein and preparing process thereof |
| 01/15/1997 | CN1140088A Buccal tablet of human leucocyte interferon and preparing method thereof |
| 01/15/1997 | CN1033810C Process for enzymatic preparation of basic fibroblast growth factor |
| 01/14/1997 | US5594120 Integrin alpha subunit |
| 01/14/1997 | US5594114 Schwann cell mitogenic factor, its preparation and use |
| 01/14/1997 | US5594113 Isolated from horseshoe crabs; treating septic shock |
| 01/14/1997 | US5594106 Inhibitors of TNF-α secretion |
| 01/14/1997 | US5594105 Peptide inhibitors of mitogenesis and motogenesis |
| 01/14/1997 | US5594104 Anti-obesity proteins |
| 01/14/1997 | US5594101 Anti-obesity proteins |
| 01/14/1997 | US5594032 Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593974 Localized oligonucleotide therapy |
| 01/14/1997 | US5593971 Alone or in combinaation with angiotensin converting enzyme inhibitor |
| 01/14/1997 | US5593969 Lipid-A analogs: monosaccharide and dissaccharide compounds for inhibiting binding of lipid A receptors to lipid A receptors |
| 01/14/1997 | US5593968 Virus-inactivated factor Xa preparation |
| 01/14/1997 | US5593967 Cholecystokinin antagonists, their preparation and therapeutic use |
| 01/14/1997 | US5593966 Peptide derivatives of cytochrome b558 and their use as medicaments |
| 01/14/1997 | US5593965 Anti-tumor effects of GnRH-III |
| 01/14/1997 | US5593964 Method of treating septic shock by preventing actin polymerization |
| 01/14/1997 | US5593963 Expression of phytase in plants |
| 01/14/1997 | US5593962 Treating calcium deficiency |
| 01/14/1997 | US5593960 Producing cyclomarin a from fermentation of streptomyces |
| 01/14/1997 | US5593959 Anticoagulants |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593882 Selectin variants |
| 01/14/1997 | US5593878 Recombinant phospholipase A2 enzyme |
| 01/14/1997 | US5593877 Nucleic acid and recombinant production of vespid venom hyaluronidase |
| 01/14/1997 | US5593876 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/14/1997 | US5593866 Cationic peptides and method for production |
| 01/14/1997 | US5593863 Administration of an RNA stem loop structure to modulate protein synthesis |
| 01/14/1997 | US5593859 Gene codes and polypeptides for cells |
| 01/14/1997 | US5593857 Production of homogeneous truncated CNTF |
| 01/14/1997 | US5593846 Methods for the detection of soluble β-amyloid peptide |
| 01/14/1997 | US5593844 Ligand-mediated immunofunctional hormone binding protein assay method |
| 01/14/1997 | US5593837 Clinical disorders associated with carboxypeptidase E mutation |
| 01/14/1997 | US5593833 Bone disorders |
| 01/14/1997 | US5593698 Immunosuppressants |
| 01/14/1997 | US5593697 Single dose vaccination system |
| 01/14/1997 | US5593677 Antimonoclonal antibodies for leukemia |
| 01/14/1997 | US5593676 Method of killing B cells using antibodies which bind CDIM |
| 01/14/1997 | US5593674 Coagulants |